Cargando…
Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities
Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new cases to be diagnosed in 2022 and representing the 7th most common cancer in women. While thyroid nodules are very common, being identified in over 60% of randomly selected adults, only 5-15% of thyroid nodules harbo...
Autores principales: | Patel, Jena, Klopper, Joshua, Cottrill, Elizabeth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999006/ https://www.ncbi.nlm.nih.gov/pubmed/36909304 http://dx.doi.org/10.3389/fendo.2023.1101410 |
Ejemplares similares
-
Editorial: Thyroid nodule evaluation: current, evolving, and emerging tools
por: Garber, Jeffrey R., et al.
Publicado: (2023) -
Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022) -
Preoperative Molecular Markers in Thyroid Nodules
por: Sahli, Zeyad T., et al.
Publicado: (2018) -
Thyroid Nodule Molecular Testing: Is It Ready for Prime Time?
por: Khan, Tahsin M., et al.
Publicado: (2020) -
Diagnostic performance of C-TIRADS combined with SWE for the diagnosis of thyroid nodules
por: Gao, Xiao-Qiang, et al.
Publicado: (2022)